P: (516) 377-8200 | F: (516) 377-8233

Posts Tagged ‘FDA’

FDA Expands TAVR Indication to Low-Risk Patients

Hot off the Press…The U.S. Food and Drug Administration (FDA) approves an expanded indication for several transcatheter heart valves (Sapien 3, Sapien 3 Ultra, CoreValve Evolut R and CoreValve Evolut PRO) to include patients with severe aortic valve stenosis at low surgical risk. According to the FDA, the incidence of aortic valve stenosis increases with age.…

Read More

Study Says Noninvasive Ear-Clip Nerve Stimulation Suppresses AFib

Researchers say they have identified a new approach that could change the way patients are treated for atrial fibrillation (AF).   They report that a randomized clinical trial effectively used nerve stimulation through an ear clip to reduce AF burden and showcases an emerging noninvasive treatment option for patients. AF is considered the most common abnormal heart…

Read More